Cyclerion Therapeutics, Inc.
sGC stimulators

Last updated:

Abstract:

Compounds of Formulae I' and I are described, which are useful as stimulators of sGC, particularly NO-independent, heme-dependent stimulators. These compounds are also useful for treating, preventing or managing various disorders that are herein disclosed. ##STR00001##

Status:
Grant
Type:

Utility

Filling date:

13 Mar 2020

Issue date:

28 Dec 2021